Company overview
biocrates provides quantitative metabolomics kits and services for targeted profiling of lipids and small molecules in biological samples, enabling pharma and life sciences researchers to quantify hundreds to over 1,800 biomarkers from minimal volumes like 10-40 µL of serum, plasma, urine, or feces. Kits such as MxP Quant 500, 500 XL, and 1000 offer reproducible, high-throughput analysis in 96-well format, supported by WebIDQ software for automated workflows, quality controls, and pathway insights via sums and ratios. With over 20 years of experience, their standardized technology is used by pharma, CROs, and core facilities worldwide for R&D in metabolism, microbiome, and clinical research.
Structured facts
- Website
- https://biocrates.com/
- Markets served
- United States & Americas
- Keywords
- biocrates, metabolomics kits, quantitative metabolomics, lipidomics, pharma r&d
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What metabolomics kits does biocrates offer and what do they cover?
- biocrates offers kits like MxP Quant 500 (up to 630 metabolites from 26 classes), MxP Quant 500 XL (over 1,000 compounds from 39 classes), and MxP Quant 1000 (up to 1,881 biomarkers), quantifying lipids, small molecules, and microbiome-related metabolites from biofluids and feces.
- What sample types and throughput capabilities are supported?
- Kits work with minimal volumes (10-40 µL) of serum, plasma, urine, and fecal samples in 96-well plates, enabling up to 240 samples per week per instrument with high reproducibility and multi-species compatibility.
- What software and support features ensure regulatory compliance and ease of use?
- WebIDQ software provides guided workflows, automated peak picking, quality controls, and MetaboINDICATOR for 400+ pathway ratios; kits include standardized protocols, cloud integration, and expert support for reproducible, validated results suitable for pharma R&D.
Related editorial coverage
- Pharma R&D ROI: A Multidimensional Framework for AI Investment Success
- Eli Lilly Dominates Pharma R&D Performance Rankings, Setting New Benchmarks
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
Explore lab tools and QA/QC resources for R&D teams.
